A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...
